GRAY JOHN T. 4
4 · Audentes Therapeutics, Inc. · Filed Oct 2, 2018
Insider Transaction Report
Form 4
GRAY JOHN T.
Senior Vice President, R & D
Transactions
- Exercise/Conversion
Common Stock
2018-09-28$1.05/sh+87$91→ 87 total - Exercise/Conversion
Stock Option (right to buy)
2018-09-28−87→ 71,669 totalExercise: $1.05Exp: 2024-09-17→ Common Stock (87 underlying) - Sale
Common Stock
2018-09-28$40.00/sh−87$3,480→ 0 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
- [F2]The option vested as to 25% of the total shares on July 14, 2015, and then 6.25% of the total shares vest quarterly thereafter, with 100% of the total shares vested and exercisable on July 14, 2018, subject to the reporting person's provision of service to the issuer on each vesting date and to accelerated vesting in the event of the occurrence of certain events.